new england journal

Drug-resistant gonorrhea becoming serious problem

NYDailyNews.com - Health - NY Daily News  Mon, 02/13/2012 - 11:13

Researchers are issuing more dire warnings about the growing threat of multi-drug-resistant gonorrhea in the US, according to a new paper published the New England Journal of Medicine.


 

University of Maryland finds restricting post-surgery blood tran...

EurekAlert! - Medicine and Health  Tue, 12/13/2011 - 23:00

(University of Maryland Medical Center) More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists.

The study found no significant difference in rate of recovery between patients who received transfusions at a moderate level of anemia and those who did not receive transfusions until their anemia was more advanced.


 

Clinical trial shows first evidence that anal cancer is preventa...

EurekAlert! - Cancer  Tue, 10/25/2011 - 22:00

(University of California - San Francisco) A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.


 

First results from Phase 3 trial show malaria vaccine candidate ...

EurekAlert! - Infectious and Emerging Diseases  Mon, 10/17/2011 - 22:00

(Burness Communications) First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.

The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.


 

Johnson and Johnson Pleads Guilty - a Reminder of the "Lost Deca...

Health Care Renewal  Thu, 09/22/2011 - 13:35

It was just a short article in Bloomberg about yet another misstep by Johnson and Johnson....

Johnson & Johnson (JNJ)’s Scios unit agreed to pay an $85 million fine and plead guilty to misbranding the heart drug Natrecor, the U.S. said.


 

Federal investment in electronic health records likely to reap r...

EurekAlert! - Medicine and Health  Tue, 08/30/2011 - 22:00

(Case Western Reserve University) Research published in the New England Journal of Medicine gives cause for optimism that federal investments in electronic health records (EHRs) could reap major benefits in better patient care and health outcomes.A study based in the Cleveland (Ohio) area involving more than 27,000 adults with diabetes found that those in physician practices using EHRs were significantly more likely to have health care and outcomes that align with accepted standards than those where doctors rely on paper records.


 

Pacific Biosciences DNA sequencing technology yields new insight...

EurekAlert! - Infectious and Emerging Diseases  Tue, 07/26/2011 - 22:00

(Bioscribe) An international team of scientists has successfully employed single molecule, real-time (SMRT) DNA sequencing technology from Pacific Biosciences of California Inc. to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak.

Published online today in the New England Journal of Medicine, the results provide the most detailed genetic profile to date of the outbreak strain, including medically relevant information.


 

Study Examines the Placebo Response in Patients With Asthma

NCCAM Featured Content  Fri, 07/15/2011 - 13:25

A recent study sheds light on the placebo's effect on subjective and objective outcome measures in clinical trials.

The study, published in The New England Journal of Medicine, was conducted by researchers at Harvard Medical School in Boston; Endicott College in Beverly, Massachusetts; and the University of Hull in the United Kingdom.